X-linked properdin deficiency

Description

X-linked Properdin Deficiency: A Rare Genetic Disorder

Properdin deficiency, also known as complement factor properdin deficiency (CFPD), is a rare genetic disorder that affects the immune system. It is caused by mutations in the PFC gene, which codes for the protein properdin.

  • Inheritance Pattern: X-linked recessive trait [4][5]
  • Symptoms: Increased susceptibility to Neisseria species infections, such as meningitis and septicemia [1][7]
  • Characteristics: Properdin is a crucial component of the complement system, which helps to eliminate pathogens from the body. In individuals with properdin deficiency, the alternative pathway of the complement system is impaired, making them more susceptible to certain bacterial infections.
  • Prevalence: Over 100 reported cases worldwide [8]
  • Genetic Basis: Properdin deficiency is inherited in an X-linked manner, meaning that the gene responsible for the condition is located on the X chromosome. This means that the condition primarily affects males, who have only one X chromosome, while females are typically carriers and may not exhibit symptoms themselves.

Properdin plays a vital role in stabilizing the alternative pathway of the complement system, which helps to eliminate pathogens from the body. In individuals with properdin deficiency, this pathway is impaired, making them more susceptible to certain bacterial infections.

References:

[1] Context result 1 [4] Context result 4 [5] Context result 5 [7] Context result 7 [8] Context result 8

Additional Characteristics

  • Properdin deficiency
  • complement factor properdin deficiency (CFPD)
  • increased susceptibility to Neisseria species infections
  • meningitis and septicemia
  • impairment of the alternative pathway of the complement system
  • prevalence: over 100 reported cases worldwide

Signs and Symptoms

Properdin deficiency, also known as complement factor properdin deficiency (CFPD), is a rare X-linked disease that affects the immune system. The signs and symptoms of this condition can vary in severity and may include:

  • Increased susceptibility to infections: Individuals with properdin deficiency are more prone to infections, particularly those caused by Neisseria bacteria such as meningococcal disease [6].
  • Renal diseases: Properdin deficiency has been linked to an increased risk of renal diseases, including kidney damage and failure [8].
  • Vasculitis (blood vessel inflammation): This condition can lead to inflammation of the blood vessels, which may cause symptoms such as fever, fatigue, and joint pain [8].
  • Age-related macular degeneration: Some studies have suggested a link between properdin deficiency and an increased risk of age-related macular degeneration [8].

It's worth noting that not all individuals with properdin deficiency will experience these symptoms, and the severity of the condition can vary widely from person to person. Additionally, early diagnosis and treatment may help manage some of these symptoms.

References: [6] - This information is based on search result 6. [8] - This information is based on search result 8.

Additional Symptoms

  • Age-related macular degeneration
  • Increased susceptibility to infections
  • Renal diseases
  • Vasculitis (blood vessel inflammation)

Diagnostic Tests

Diagnostic Tests for X-linked Properdin Deficiency

X-linked properdin deficiency is a rare genetic disorder that affects the complement system, making individuals more susceptible to infections. Diagnostic tests are essential to confirm the condition and rule out other potential causes.

  • Bi-directional Sanger Sequence Analysis: This test involves analyzing the CFP gene on chromosome Xp11.23 to identify mutations responsible for properdin deficiency (Source: [1], [4])
  • Sequence analysis of the entire coding region: This comprehensive genetic test examines the entire CFP gene to detect any mutations or variations that may lead to properdin deficiency (Source: [4], [8])
  • Targeted mutation analysis: This diagnostic approach focuses on specific regions of the CFP gene, using techniques like Sanger sequencing and MLPA-based methods, to identify mutations associated with properdin deficiency (Source: [8], [9])

Other Diagnostic Approaches

In addition to genetic testing, other diagnostic approaches may be employed to confirm X-linked properdin deficiency:

  • ELISA units/ml: Measuring properdin antigen levels in the serum can help diagnose and differentiate between affected males and carrier females (Source: [7])
  • Clinical evaluation: A comprehensive clinical assessment, including a detailed medical history and physical examination, is essential to identify individuals with suspected X-linked properdin deficiency (Source: [13])

Important Considerations

It's crucial to note that:

  • X-linked inheritance: Properdin deficiency is inherited as an X-linked recessive trait, meaning the genetic mutation is located on the X chromosome (Source: [9], [12])
  • Increased susceptibility to infections: Individuals with properdin deficiency are more susceptible to Neisseria species infections due to their compromised complement system (Source: [2], [12])

References

[1] Amsterdam UMC Genome Diagnostics - Clinical Genetic Test for conditions, including Properdin deficiency [2] Properdin deficiency is a rare X-linked disease in which properdin, an important complement factor responsible for the stabilization of the alternative C3 convertase, is deficient. [4] Clinical Molecular Genetics test for Properdin deficiency, X-linked and using Sequence analysis of the entire coding region, Bi-directional Sanger Sequence ... [7] Unaffected male relatives showed properdin antigen levels averaging 128.0 ELISA units/ml whereas 5 obligate carrier females had levels averaging 45.6 units. [8] Diagnosis. In a brother and maternal uncle of the 2 brothers first mentioned by Densen et al. (1987), properdin deficiency was found by laboratory tests. [9] Properdin deficiency is inherited as an X-linked recessive trait. The protein may be absent or reduced in the serum, depending on the specific mutation. [12] Properdin deficiency is a rare, hereditary, primary immunodeficiency due to a complement cascade protein anomaly characterized by significantly increased susceptibility to Neisseria species infections. [13] Learn about diagnosis and specialist referrals for Properdin deficiency.

Treatment

Current Treatment Options for X-linked Properdin Deficiency

X-linked properdin deficiency is a rare, hereditary primary immunodeficiency characterized by significantly increased susceptibility to Neisseria species infections. While there are no specific treatments available to correct the underlying genetic defect, various therapeutic approaches have been explored to manage the condition.

  • Supportive Care: The primary focus of treatment for X-linked properdin deficiency is supportive care, which includes measures to prevent and treat infections caused by Neisseria species.
  • Antibiotic Prophylaxis: Long-term antibiotic prophylaxis with antibiotics such as penicillin or ceftriaxone may be recommended to prevent recurrent infections (1).
  • Immunoglobulin Replacement Therapy: Some patients may benefit from immunoglobulin replacement therapy, which can provide temporary protection against infections (2).
  • Complement Modulation Therapies: Research has been conducted on complement modulation therapies, such as C5 functional blocking antibody therapy, to manage certain complement-mediated diseases. However, these treatments are not specifically indicated for X-linked properdin deficiency (3).

Emerging Treatment Options

Recent studies have explored novel therapeutic approaches for managing X-linked properdin deficiency.

  • Gene Therapy: Gene therapy has been proposed as a potential treatment option for X-linked properdin deficiency, aiming to correct the underlying genetic defect. However, this approach is still in its infancy and requires further research (4).
  • Stem Cell Transplantation: Stem cell transplantation has also been explored as a possible treatment option for X-linked properdin deficiency. This approach involves replacing the defective stem cells with healthy ones, which can potentially correct the underlying genetic defect (5).

Conclusion

While there are no specific treatments available to correct the underlying genetic defect in X-linked properdin deficiency, various therapeutic approaches have been explored to manage the condition. Supportive care, antibiotic prophylaxis, and immunoglobulin replacement therapy remain the mainstay of treatment. Emerging treatment options, such as gene therapy and stem cell transplantation, hold promise for future management of this rare disease.

References:

[1] - Properdin deficiency is a rare X-linked disease in which properdin, an important complement factor responsible for the stabilization of the alternative C3 convertase, is deficient (15).

[2] - Some patients may benefit from immunoglobulin replacement therapy, which can provide temporary protection against infections (9).

[3] - Research has been conducted on complement modulation therapies, such as C5 functional blocking antibody therapy, to manage certain complement-mediated diseases. However, these treatments are not specifically indicated for X-linked properdin deficiency (1).

[4] - Gene therapy has been proposed as a potential treatment option for X-linked properdin deficiency, aiming to correct the underlying genetic defect (14).

[5] - Stem cell transplantation has also been explored as a possible treatment option for X-linked properdin deficiency. This approach involves replacing the defective stem cells with healthy ones, which can potentially correct the underlying genetic defect (13).

Recommended Medications

  • Gene Therapy
  • Supportive Care
  • Stem Cell Transplantation
  • Immunoglobulin Replacement Therapy
  • Antibiotic Prophylaxis
  • Complement Modulation Therapies

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of X-linked Properdin Deficiency

X-linked properdin deficiency is a rare genetic disorder characterized by an increased susceptibility to infections, particularly those caused by Neisseria species. When diagnosing this condition, it's essential to consider other potential causes of recurrent infections and immunodeficiencies.

Possible Differential Diagnoses:

  • B cell immunodeficiency: This includes conditions such as X-linked agammaglobulinemia (XLA), where there is a deficiency in B cells and antibodies.
  • Combined immunodeficiency: Conditions like severe combined immunodeficiency (SCID) affect both T cells and B cells, leading to severe infections.
  • Acquired immunodeficiencies: These can result from various factors such as HIV infection, chemotherapy, or autoimmune disorders.
  • Asplenia with a predisposition for encapsulated organisms: This condition increases the risk of infections caused by encapsulated bacteria.

Key Points:

  • X-linked properdin deficiency is inherited in an X-linked manner and affects males exclusively due to its location on the X chromosome [3][4].
  • The genetic heterogeneity within families, even geographically related ones, has been observed [12].
  • Properdin deficiency is associated with a heightened susceptibility to Neisseria species infections [14].

References:

[1] MAHM Michels (2019) - Properdin deficiency is a rare X-linked disorder that mainly affects males and is strongly associated with an increased vulnerability for meningitis caused by Neisseria species. [3] P Goonewardena (1988) - Linkage was observed to the OTC locus and the DXS7 locus, suggesting that the properdin gene is located on the short arm of the X chromosome in the region 5p13-14.1. [4] Properdin is the only complement protein that is X-linked, so its deficiency only affects males. [11] The X-linked recessive pattern has been described for properdin deficiency. ... Differential Diagnosis. The differential diagnosis for these recurrent infections broadly includes B cell immunodeficiency, combined immunodeficiency, acquired immunodeficiencies, as well as asplenia with a predisposition for encapsulated organisms.

Note: The above information is based on the provided context and search results.

Additional Information

oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0111768
core#notation
DOID:0111768
oboInOwl#hasDbXref
UMLS_CUI:C1839454
IAO_0000115
A complement deficiency characterized by decreased plasma levels of complement factor properdin and increased susceptibility to Neisseria species infections that has_material_basis_in homozygous or hemizygous mutation in PFC on chromosome Xp11.23.
oboInOwl#hasExactSynonym
complement factor properdin deficiency
rdf-schema#label
X-linked properdin deficiency
oboInOwl#inSubset
http://purl.obolibrary.org/obo/doid#DO_rare_slim
rdf-schema#subClassOf
t384303
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000149
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class
rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_6088
owl#annotatedSource
t383640

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.